pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·Aug 10·1 min read
save

Aspo Oyj announces upcoming leadership changes scheduled for August 10, 2026

Aug 10, 2026·read at globenewswire health ↗Neutral

Aspo Oyj, a Finnish specialty chemicals company, issued a brief notice indicating that it will implement leadership transactions.

The announcement specifies that the changes will take effect on August 10, 2026, at 5:30 p.m. local time, though it does not detail the individuals involved or the nature of the moves.

The company has not provided additional information, and stakeholders will likely await further communication to understand the impact on the firm’s operations and strategy.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Aspo Oyj - Johdon liiketoimet”

read at globenewswire health ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • Aug 10Aspo Plc - Managers' Transactionsglobenewswire health
  • Aug 7Ledende medarbejder transaktionglobenewswire health
  • Aug 7Ledende medarbejders køb af aktierglobenewswire health
  • Aug 6Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officerglobenewswire health
  • Aug 6Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officerglobenewswire health